Immediate Impact
8 standout
Citing Papers
Bispecific antibodies: advancing precision oncology
2024 Standout
Multiple myeloma
2024 Standout
Works of Dinesh Kumar Sinha being referenced
Weekly selinexor, bortezomib, and dexamethasone (SVd) versus twice weekly bortezomib and dexamethasone (Vd) in patients with multiple myeloma (MM) after one to three prior therapies: Initial results of the phase III BOSTON study.
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dinesh Kumar Sinha | 26 | 16 | 22 | 24 | 11 | 54 | |
| Li Qin | 15 | 13 | 12 | 16 | 9 | 67 | |
| Santina Calvacchi | 26 | 15 | 19 | 35 | 9 | 163 | |
| Tripti Kumar | 16 | 9 | 5 | 17 | 9 | 47 | |
| Patricia Conde | 24 | 35 | 6 | 19 | 9 | 182 | |
| Allison Perrin | 36 | 6 | 15 | 17 | 12 | 82 | |
| Tasleema Patel | 12 | 23 | 12 | 9 | 9 | 69 | |
| Yaron Meirow | 50 | 10 | 8 | 63 | 11 | 175 | |
| Xiaman Wang | 26 | 6 | 31 | 39 | 7 | 62 | |
| Ignatius Purwanto | 59 | 16 | 24 | 43 | 11 | 182 | |
| Daniel Beug | 16 | 27 | 15 | 46 | 14 | 176 |
All Works
Login with ORCID to disown or claim papers
Loading papers...